GATAD2A Antikörper (AA 125-175)
-
- Target Alle GATAD2A Antikörper anzeigen
- GATAD2A (GATA Zinc Finger Domain Containing 2A (GATAD2A))
-
Bindungsspezifität
- AA 125-175
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser GATAD2A Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunoprecipitation (IP)
- Verwendungszweck
- Rabbit anti-p66alpha Antibody, Affinity Purified
- Aufreinigung
- Affinity Purified
- Immunogen
- between AA 125 and 175
- Isotyp
- IgG
- Top Product
- Discover our top product GATAD2A Primärantikörper
-
-
- Applikationshinweise
-
IP: 2 - 5 μg/mg lysate
WB: 1:2,000 - 1:10,000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 200 μg/mL
- Buffer
- Tris-buffered Saline containing 0.1 % BSA and 0.09 % Sodium Azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Haltbarkeit
- 12 months
-
- Target
- GATAD2A (GATA Zinc Finger Domain Containing 2A (GATAD2A))
- Andere Bezeichnung
- p66alpha (GATAD2A Produkte)
- Hintergrund
- Background: p66alpha and p66beta are human orthologs of the xenopus p66 subunit of the Mi-2/NuRD complex. The Mi-2/NuRD complex is a multi-subunit complex that mediates gene repression via processes involving chromatin remodeling and histone deacetylation. p66 alpha and beta were identified in a two-hybrid screen using the methyl-CpG-binding domain protein, MBD2, as bait. It has been demonstrated that p66alpha and p66beta mediate the interaction between MBD2 and histones.
- Gen-ID
- 54815
- UniProt
- Q86YP4
- Pathways
- Tube Formation, Embryonic Body Morphogenesis
-